Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3364

1.

Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs.

West PJ, Saunders GW, Billingsley P, Smith MD, White HS, Metcalf CS, Wilcox KS.

Epilepsia. 2018 Oct 17. doi: 10.1111/epi.14563. [Epub ahead of print]

PMID:
30328622
2.

Interleukin-1beta in synergism gabapentin with tramadol in murine model of diabetic neuropathy.

Miranda HF, Poblete P, Sierralta F, Noriega V, Prieto JC, Zepeda RJ.

Inflammopharmacology. 2018 Oct 13. doi: 10.1007/s10787-018-0532-7. [Epub ahead of print]

PMID:
30317449
3.

The pharmacokinetics of gabapentin in cats.

Adrian D, Papich MG, Baynes R, Stafford E, Lascelles BDX.

J Vet Intern Med. 2018 Oct 11. doi: 10.1111/jvim.15313. [Epub ahead of print]

4.

Modulatory role of gabapentin against ovalbumin-induced asthma, bronchial and airway inflammation in mice.

Yosri H, Said E, Elkashef WF, Gameil NM.

Environ Toxicol Pharmacol. 2018 Sep 18;64:18-25. doi: 10.1016/j.etap.2018.09.004. [Epub ahead of print]

PMID:
30286334
5.

The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery: A meta-analysis.

Jiang Y, Li J, Lin H, Huang Q, Wang T, Zhang S, Zhang Q, Rong Z, Xiong J.

Medicine (Baltimore). 2018 Sep;97(38):e11581. doi: 10.1097/MD.0000000000011581.

6.

Creatinine-Based Renal Function Estimates and Dosage of Postoperative Pain Management for Elderly Acute Hip Fracture Patients.

Houlind MB, Petersen KK, Palm H, Jørgensen LM, Aakjær M, Christrup LL, Petersen J, Andersen O, Treldal C.

Pharmaceuticals (Basel). 2018 Sep 18;11(3). pii: E88. doi: 10.3390/ph11030088.

7.

The EGF-LIKE domain of thrombospondin-4 is a key determinant in the development of pain states due to increased excitatory synaptogenesis.

Park JF, Yu YP, Gong N, Trinh VN, Luo ZD.

J Biol Chem. 2018 Oct 19;293(42):16453-16463. doi: 10.1074/jbc.RA118.003591. Epub 2018 Sep 7.

PMID:
30194282
8.

Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy.

Moavero R, Pisani LR, Pisani F, Curatolo P.

Expert Opin Drug Saf. 2018 Oct;17(10):1015-1028. doi: 10.1080/14740338.2018.1518427. Epub 2018 Sep 17. Review.

PMID:
30169997
9.

The Association of Gabapentin Use and Dose With Substance Use Disorders Prior to Inpatient Mental Health Treatment: A Cross-Sectional Study.

Tomko JR, Prasad KM, Kubas S, Simpson T.

Prim Care Companion CNS Disord. 2018 Aug 2;20(4). pii: 18m02291. doi: 10.4088/PCC.18m02291.

10.

Synergism between gabapentin-tramadol in experimental diabetic neuropathic pain.

Miranda HF, Sierralta F, Aranda N, Poblete P, Noriega V, Prieto JC.

Fundam Clin Pharmacol. 2018 Aug 1. doi: 10.1111/fcp.12400. [Epub ahead of print]

PMID:
30069908
11.

A viewpoint on rational and irrational fixed-drug combinations.

Błaszczyk B, Miziak B, Czuczwar P, Wierzchowska-Cioch E, Pluta R, Czuczwar SJ.

Expert Rev Clin Pharmacol. 2018 Aug;11(8):761-771. doi: 10.1080/17512433.2018.1500895. Epub 2018 Jul 23. Review.

PMID:
30024271
12.

Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.

Foley DW, Pathak RB, Phillips TR, Wilson GL, Bailey PD, Pieri M, Senan A, Meredith D.

Eur J Med Chem. 2018 Aug 5;156:180-189. doi: 10.1016/j.ejmech.2018.06.064. Epub 2018 Jun 30.

13.

Evaluation of the antinociceptive activities of several sodium channel blockers using veratrine test in mice.

Yoshizawa K, Arai N, Suzuki Y, Nakamura T, Takeuchi K, Sakamoto R, Masuda R.

Synapse. 2018 Jul 11. doi: 10.1002/syn.22056. [Epub ahead of print]

PMID:
29993143
14.

Gabapentin and NMDA receptor antagonists interacts synergistically to alleviate allodynia in two rat models of neuropathic pain.

Shi T, Hao JX, Wiesenfeld-Hallin Z, Xu XJ.

Scand J Pain. 2018 Oct 25;18(4):687-693. doi: 10.1515/sjpain-2018-0083.

PMID:
29975670
15.

Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents.

Kunisawa N, Shimizu S, Kato M, Iha HA, Iwai C, Hashimura M, Ogawa M, Kawaji S, Kawakita K, Abe K, Ohno Y.

J Pharmacol Sci. 2018 Jun;137(2):162-169. doi: 10.1016/j.jphs.2018.05.007. Epub 2018 Jun 7.

16.

On the addictive power of gabapentinoids: a mini-review.

Bonnet U, Richter EL, Isbruch K, Scherbaum N.

Psychiatr Danub. 2018 Jun;30(2):142-149. doi: 10.24869/psyd.2018.142. Review.

17.

Pharmacological therapies for management of opium withdrawal.

Rahimi-Movaghar A, Gholami J, Amato L, Hoseinie L, Yousefi-Nooraie R, Amin-Esmaeili M.

Cochrane Database Syst Rev. 2018 Jun 21;6:CD007522. doi: 10.1002/14651858.CD007522.pub2. Review.

PMID:
29929212
18.

The effects of gabapentin in human experimental pain models.

Enggaard TP, Mikkelsen SS, Zwisler ST, Klitgaard NA, Sindrup SH.

Scand J Pain. 2010 Jul 1;1(3):143-148. doi: 10.1016/j.sjpain.2010.04.001.

PMID:
29913969
19.

Co-administered gabapentin and venlafaxine in nerve injured rats: Effect on mechanical hypersensitivity, motor function and pharmacokinetics.

Folkesson A, Honoré PH, Bjerrum OJ.

Scand J Pain. 2010 Apr 1;1(2):91-97. doi: 10.1016/j.sjpain.2009.12.001.

PMID:
29913946
20.

Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence.

Tomić M, Pecikoza U, Micov A, Vučković S, Stepanović-Petrović R.

Pharmacol Ther. 2018 Jun 15. pii: S0163-7258(18)30104-9. doi: 10.1016/j.pharmthera.2018.06.002. [Epub ahead of print] Review.

PMID:
29909236

Supplemental Content

Loading ...
Support Center